Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Sahn

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Chest|May 11, 2006
Patient perspectives on management of pneumothorax in lymphangioleiomyomatosisLisa R Young, Khalid F Almoosa, Stacey Pollock-Barziv, et al.
International Journal of Rheumatic Diseases|June 19, 2013
Pulmonary capillaritis in a patient with moderately positive anti-PL-12 antibodiesCarlos E Kummerfeldt, John T Huggins, Ellen C Riemer, et al.
Chest|September 7, 2013
Improving the predictive accuracy of identifying exudative effusionsCarlos E Kummerfeldt, Cody C Chiuzan, John T Huggins, et al.
Clinical Medicine Insights. Case Reports|August 27, 2015
Pleural Fluid Analysis in Chronic Hemothorax: A Mimicker of InfectionMatthew L DiVietro, John Terrill Huggins, Lauren Brown Angotti, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice dailyWilliam Busse, Steven M Koenig, John Oppenheimer, et al.
Respiratory Medicine|March 30, 2010
Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis A study of patients less than 40 years-old in an area with a high incidence of tuberculosisLuis Valdés, Maria Esther San José, Antonio Pose, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 4, 2014
Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosisUlrich Costabel, Carlo Albera, Williamson Z Bradford, et al.
Chest|May 11, 2006
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complicationsKhalid F Almoosa, Jay H Ryu, Jose Mendez, et al.
Respirology (Carlton, Vic.)|May 20, 2014
Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosisDominique Valeyre, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal|December 7, 2013
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisRoland M du Bois, Carlo Albera, Williamson Z Bradford, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Chest|May 11, 2006
Patient perspectives on management of pneumothorax in lymphangioleiomyomatosisLisa R Young, Khalid F Almoosa, Stacey Pollock-Barziv, et al.
International Journal of Rheumatic Diseases|June 19, 2013
Pulmonary capillaritis in a patient with moderately positive anti-PL-12 antibodiesCarlos E Kummerfeldt, John T Huggins, Ellen C Riemer, et al.
Chest|September 7, 2013
Improving the predictive accuracy of identifying exudative effusionsCarlos E Kummerfeldt, Cody C Chiuzan, John T Huggins, et al.
Clinical Medicine Insights. Case Reports|August 27, 2015
Pleural Fluid Analysis in Chronic Hemothorax: A Mimicker of InfectionMatthew L DiVietro, John Terrill Huggins, Lauren Brown Angotti, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice dailyWilliam Busse, Steven M Koenig, John Oppenheimer, et al.
Respiratory Medicine|March 30, 2010
Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis A study of patients less than 40 years-old in an area with a high incidence of tuberculosisLuis Valdés, Maria Esther San José, Antonio Pose, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 4, 2014
Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosisUlrich Costabel, Carlo Albera, Williamson Z Bradford, et al.
Chest|May 11, 2006
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complicationsKhalid F Almoosa, Jay H Ryu, Jose Mendez, et al.
Respirology (Carlton, Vic.)|May 20, 2014
Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosisDominique Valeyre, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal|December 7, 2013
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisRoland M du Bois, Carlo Albera, Williamson Z Bradford, et al.
Pageof 8